You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 18, 2025

Details for Patent: 6,225,294


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,225,294
Title: Method for inhibiting bone resorption
Abstract:Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein.
Inventor(s): Daifotis; Anastasia G. (Westfield, NJ), Santora, II; Arthur C. (Watchung, NJ), Yates; A. John (Westfield, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/440,577
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,225,294

Introduction to Patent Analysis

When analyzing a patent, it is crucial to understand the scope of the claims, the patent's position within the broader patent landscape, and the legal and procedural aspects that govern its validity and enforcement. This article will delve into the specifics of United States Patent 6,225,294, although the patent itself is not provided in the sources, we will use general principles and relevant examples to illustrate key points.

What is a Patent?

A patent is a government-granted monopoly that gives the inventor exclusive rights to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[4].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks. The USPTO evaluates patent applications to ensure that the inventions meet the criteria of novelty, non-obviousness, and utility[2].

Patent Claims

Patent claims are the most critical part of a patent as they define the scope of the invention. Claims are statements that describe the invention and set the boundaries of what is protected by the patent. There are two main types of claims: independent claims and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim[4].

Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics can provide insights into the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims[3].

Patent Family and Continuations

Patents can be part of a larger family, including continuations, continuations-in-part, and divisional applications. Each member of the patent family can have different claims and expiration dates, especially if they receive Patent Term Adjustments (PTA) for delays during prosecution. This complexity can lead to issues such as obviousness-type double patenting (ODP), where claims in later patents may be deemed unpatentable over earlier patents in the same family[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents the granting of multiple patents for the same invention or obvious variants of the same invention. This doctrine is particularly relevant for patents within the same family that claim priority from a single application. For example, in the case of Cellect LLC, claims in later patents were found to be unpatentable over earlier patents in the same family due to ODP[1].

Patent Term Adjustments (PTA)

PTA is a mechanism to adjust the term of a patent to compensate for delays during the prosecution process. However, PTA can also complicate the patent landscape by extending the life of some patents beyond the standard 20-year term from the filing date of the priority application. This can lead to situations where different members of a patent family have different expiration dates, affecting their validity and enforceability[1].

Legal and Procedural Aspects

Patent validity can be challenged through various proceedings, including reexamination and inter partes review. In these proceedings, the patent office or a court may determine that the claims are invalid due to prior art, obviousness, or other grounds. For instance, in the case of Cellect LLC, the examiner issued Final Office Actions determining that the challenged claims were obvious variants of earlier patent claims[1].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. Such a court could provide a more streamlined and cost-effective way for smaller entities to resolve patent disputes, potentially affecting the enforcement and validity of patents like 6,225,294[5].

Industry Expert Insights

Industry experts and legal practitioners often emphasize the importance of clear and narrow claims to avoid issues of patent scope and validity. For example, Andrei Iancu, former Undersecretary of Commerce for IP and Director of the USPTO, has highlighted the need for patent quality and clarity to promote innovation and reduce litigation costs[5].

Illustrative Statistics

Studies have shown that patents with narrower claims tend to have a higher grant rate and shorter examination times. For instance, a study on patent scope found that narrower claims at publication were associated with a 10% higher grant rate compared to broader claims[3].

Key Takeaways

  • Patent Claims: The scope of a patent is defined by its claims, which must be clear, novel, and non-obvious.
  • Patent Family: Patents within the same family can have different claims and expiration dates, especially with PTA.
  • ODP: Obviousness-type double patenting prevents the granting of multiple patents for the same invention or obvious variants.
  • PTA: Patent Term Adjustments can extend the life of patents but complicate the patent landscape.
  • Legal Proceedings: Patent validity can be challenged through reexamination and inter partes review.
  • Small Claims Court: A potential small claims patent court could streamline patent dispute resolution.

FAQs

Q: What is the primary role of the USPTO in the patent process? A: The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventions meet the criteria of novelty, non-obviousness, and utility.

Q: How is the scope of a patent measured? A: The scope of a patent can be measured using metrics such as independent claim length and independent claim count.

Q: What is obviousness-type double patenting (ODP)? A: ODP is a doctrine that prevents the granting of multiple patents for the same invention or obvious variants of the same invention.

Q: How do Patent Term Adjustments (PTA) affect patents? A: PTA can extend the life of patents to compensate for delays during prosecution but can also complicate the patent landscape by creating different expiration dates within a patent family.

Q: Why is there a discussion about a small claims patent court? A: A small claims patent court is proposed to provide a more streamlined and cost-effective way for smaller entities to resolve patent disputes.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Patent Law in the United States - BitLaw
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,225,294

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,225,294

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 0998292 ⤷  Try for Free CA 2006 00005 Denmark ⤷  Try for Free
European Patent Office 0998292 ⤷  Try for Free PA2006002 Lithuania ⤷  Try for Free
European Patent Office 0998292 ⤷  Try for Free 91222 Luxembourg ⤷  Try for Free
European Patent Office 0998292 ⤷  Try for Free PA2006002,C0998292 Lithuania ⤷  Try for Free
European Patent Office 1175904 ⤷  Try for Free PA2007007 Lithuania ⤷  Try for Free
European Patent Office 1175904 ⤷  Try for Free CA 2007 00045 Denmark ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.